L3VLUP
ProSign in

OFIX · VRTX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

OFIXVRTX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • OFIX
  • VRTX
010203040202120222023202420252026
Holders and value by quarter
QuarterOFIXVRTX
Q3 20202 holders, $14m31 holders, $21.9bn
Q4 20203 holders, $29m30 holders, $18.4bn
Q1 20213 holders, $27m31 holders, $15.4bn
Q2 20213 holders, $15m30 holders, $12.7bn
Q3 20213 holders, $14m35 holders, $10.1bn
Q4 20213 holders, $9.8m28 holders, $12.4bn
Q1 20223 holders, $12m23 holders, $16.1bn
Q2 20223 holders, $13m25 holders, $18.1bn
Q3 20222 holders, $14m22 holders, $18.4bn
Q4 20223 holders, $14m28 holders, $18.4bn
Q1 20232 holders, $1.9m26 holders, $21.4bn
Q2 20232 holders, $13m27 holders, $24.7bn
Q3 20232 holders, $8.6m33 holders, $24.3bn
Q4 20232 holders, $10m32 holders, $28.6bn
Q1 20242 holders, $15m31 holders, $29.8bn
Q2 20242 holders, $17m29 holders, $33.4bn
Q3 20242 holders, $3.4m27 holders, $33.5bn
Q4 20241 holders, $2.7m26 holders, $28.5bn
Q1 20251 holders, $2.6m21 holders, $35.4bn
Q2 2025none listed holders, n.a.21 holders, $32.3bn
Q3 20251 holders, $2.5m22 holders, $25.9bn
Q4 20251 holders, $2.6m26 holders, $31.8bn
Q1 20261 holders, $2.3m25 holders, $31.8bn
Q2 2026none listed holders, n.a.26 holders, $34.6bn
OFIX

Orthofix Med Inc

Holders
0
Reported value
$0
Buyers
n.a.
Sellers
n.a.

No cross-section for this quarter.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
VRTX

Vertex Pharmaceuticals Inc

Holders
21
Reported value
$32.3bn
Buyers
11
Sellers
11

Breadth 0 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 21 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Both (0)

No tracked manager lists every one of them.

Only OFIX (0)

None.

Only VRTX (21)

AllianceBernstein LP, AQR Capital Management LLC, ARK Investment Management LLC, Artisan Partners LP, Baillie Gifford & Co, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Neuberger Berman Group LLC, Renaissance Technologies LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Wellington Management Group LLP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →